Biodesix Inc. (BDSX): Price and Financial Metrics
BDSX Price/Volume Stats
Current price | $1.30 | 52-week high | $2.21 |
Prev. close | $1.70 | 52-week low | $1.15 |
Day low | $1.28 | Volume | 556,000 |
Day high | $1.67 | Avg. volume | 149,753 |
50-day MA | $1.72 | Dividend yield | N/A |
200-day MA | $1.60 | Market Cap | 188.73M |
BDSX Stock Price Chart Interactive Chart >
Biodesix Inc. (BDSX) Company Bio
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.
BDSX Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...